Clinical trials recruiting for Renal Cell Carcinoma (Kidney Cancer)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Adagrasib | 1 |
| Cabozantinib | 1 |
| Darlifarnib | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Tennessee | 3 |
| Arizona | 2 |
| California | 2 |
| Florida | 2 |
| Massachusetts | 2 |
| Minnesota | 2 |
| Missouri | 2 |
| Ohio | 2 |
| Texas | 2 |
| Colorado | 1 |
| Iowa | 1 |
| Michigan | 1 |
Top cities
Self-screener
Recruiting trials
- Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
- KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
- Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance
- Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Targeted Abdominal CT in Conjunction With Lung Cancer Screening
Related conditions
Trials recruiting for Renal Cell Carcinoma (Kidney Cancer) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Renal Cell Carcinoma (Kidney Cancer) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.